J. Goldman & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,000
Closed -$6.21M 774
2025
Q4
$6.21M Sell
30,000
-10,000
-25% -$1.98M 0.16% 168
2025
Q3
$7.42M Buy
40,000
+20,000
+100% +$3.43M 0.19% 149
2025
Q2
$3.06M Buy
+20,000
New +$3.07M 0.07% 246
2023
Q3
Sell
-150,500
Closed -$24.9M 421
2023
Q2
$24.9M Buy
+150,500
New +$24.3M 0.91% 24

Other funds holding JNJ

J. Goldman & Co's JNJ Position: Q1 2026 in Review

J. Goldman & Co reduced its Johnson & Johnson (JNJ) stake by 96% in Q1 2026, selling an estimated $14.7M and leaving 2,900 shares worth $709K. The position accounts for 0.02% of the portfolio, ranked #463.

J. Goldman & Co first reported a position in JNJ in Q3 2022 and has held it in 4 quarters since. The position peaked at $26.6M in Q2 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • J. Goldman & Co held 2,900 shares of Johnson & Johnson worth $709K as of Q1 2026.
  • J. Goldman & Co sold 63,081 Johnson & Johnson shares in Q1 2026, an estimated $14.7M.
  • Johnson & Johnson made up 0.02% of J. Goldman & Co's portfolio in Q1 2026, its #463 holding.
  • J. Goldman & Co first reported a position in Johnson & Johnson in Q3 2022 and has held it in 4 quarters since.
  • J. Goldman & Co's Johnson & Johnson position peaked at $26.6M in Q2 2023.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.